ClinicalTrials HQ

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Recruiting · NCT07041099 · Registry updated 2026-08-11
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseaseSjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorderRecruitingPhase 12026-08-11NCT07041099

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cullinan Therapeutics Inc.10

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CHU BrestBrestFrance30
Chu NantesNantesFrance45
CHU St.-ÉtienneSaint-Priest-en-JarezFrance1
CHU Strasbourg-HautepierreStrasbourgFrance8
Fondazione Policlinico Universitario A GemelliRomaItaly2
Hannover Medical SchoolHanoverGermany19
Hopitaux Universitaires Paris-SudLe Kremlin-BicêtreFrance1
IntermountainSalt Lake CityUnited States1
New York UniversityBrooklynUnited States1
Omega ResearchOrlandoUnited States2
Regional OneMemphisUnited States1
Stryde ResearchPlanoUnited States4
Tranquil ResearchWebsterUnited States3
University Hospital ErlangenErlangenGermany9